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Several studies have reported that bone marrow (BM) cells may give rise to neurons and 
astrocytes in vitro and in vivo. To further test this hypothesis, we analyzed for incorporation 
of neural cell types expressing donor markers in normal or injured brains of irradiated mice 
reconstituted with whole BM or single, purified c-kit
 
 
 
Thy1.1
 
lo
 
Lin
 
 
 
Sca-1
 
 
 
 (KTLS) 
hematopoietic stem cells (HSCs), and of unirradiated parabionts with surgically anastomosed 
vasculature. Each model showed low-level parenchymal engraftment of donor-marker
 
 
 
 cells 
with 96–100% immunoreactivity for panhematopoietic (CD45) or microglial (Iba1 or Mac1) 
lineage markers in all cases studied. Other than one arborizing structure in the olfactory 
bulb of one BM-transplanted animal, possibly representing a neuronal or glial cell process, 
we found no donor-marker–expressing astrocytes or non-Purkinje neurons among 
 
 
 
10,000 
donor-marker
 
 
 
 cells from 21 animals. These data strongly suggest that HSCs and their 
progeny maintain lineage fidelity in the brain and do not adopt neural cell fates with any 
measurable frequency.
 
Much has been published in the past few years
regarding the potential plasticity of hematopoi-
etic stem cells (HSCs). In particular, multiple
reports have suggested that rodent and human
BM cells and BM HSCs can acquire neural cell
fates both in vitro and in vivo (1–16). Several
mechanisms have been postulated to explain
this phenomenon: (a) HSCs, as a major stem
cell component of BM grafts, may “transdiffer-
entiate” to generate neurons or neuronal pre-
cursors; (b) BM HSCs may dedifferentiate to
generate pluripotent stem cells with broad dif-
ferentiation potential, and these cells are then
capable of giving rise to neurons; (c) in addi-
tion to HSCs, BM may harbor tissues specific
neuronal precursor cells, or pluripotent stem
cells, that are directly capable of homing to
and engrafting within the brain to generate
mature neurons upon transplantation; and (d)
apparent transdifferentiation from transplanted
BM or HSCs may occur via cell fusion, likely
between committed neural lineage cells and
differentiated mature myeloid cells from the
blood (for review see reference 17). Given the
serious implications of possible BM or HSC
contributions to neuronal lineages, both in the
laboratory and for clinical medicine, rigorous
analysis of claims of HSC plasticity in the neu-
ronal milieu is clearly essential to clarify this
apparent controversy.
Using confocal microscopy, we performed
immunofluorescence analysis of brains har-
vested from mice previously irradiated and
transplanted with whole BM or single, purified
c-kit
 
 
 
Thy1.1
 
lo
 
Lin
 
 
 
Sca-1
 
 
 
 (KTLS) HSCs. Do-
nor BM and HSCs were isolated from trans-
genic mice in which enhanced GFP (eGFP)
was driven by the 
 
 
 
-actin promoter, such that
all cells and tissues in these mice, except erythro-
cytes and hair, are constitutively and irreversibly
marked by bright green fluorescence. For lineage
analysis of donor-marker–expressing cells, we
used CD45 as a marker for hematopoietic cells
(18), Mac1 and Iba1 for microglia (19), NeuN
for neurons (20), glial fibrillary acidic pro-
tein (GFAP) for astrocytes, and Calbindin for
Purkinje cells. Analysis for coexpression of
CD45 was essential in this study to assay for
full conversion of donor hematopoietic cells to
a nonhematopoietic fate. To evaluate the effect
of selective pressures on the capacity of BM or
HSC-derived cells to incorporate donor mark-
ers into the brain, we analyzed contributions
from donor cells in transplanted but otherwise
unmanipulated animals and in two models of
brain injury/regeneration, as follows: (a) a hippo-
campal injury model using intraperitoneal in-
jection of kainic acid (KA) to induce seizures
and (b) running wheel exercise, known to in-
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duce hippocampal neurogenesis (21, 22). Finally, we generated
and analyzed, the in steady state and after injury to the brain,
parabiotic mouse pairs, surgically joined such that they devel-
oped a common, anastomosed vasculature. These parabiosis
experiments allowed analysis of possible neural contributions
from any blood circulating cells, including mature and imma-
ture blood progenitor cells, and circumvented the requirement
for irradiation, which, although necessary for BM or HSC
transplantation, has been shown to ablate tissue-specific neu-
ronal stem cells and inhibit neurogenesis by altering the mi-
croenvironment supporting stem cell proliferation (23–25).
Data collected from either transplanted or parabiotic ani-
mals indicate that cellular contributions from transplanted or
circulating cells both in the steady state and after injury or
induced neurogenesis are largely restricted to hematopoietic
(CD45
 
 
 
) and microglial (Iba1
 
 
 
 or Mac1
 
 
 
) lineages. Coex-
pression of donor markers with neural antigens and/or mor-
phology was exceptionally rare, and detected almost exclu-
sively among cerebellar Purkinje cells, which have been
shown previously to acquire donor markers via cell fusion
events (26–28). These data contrast with recent papers sug-
gesting that BM cells normally adopt neural cell fates at low
but detectable levels (1, 2, 4, 6, 8, 14), and suggest that HSC
and their progeny maintain lineage fidelity within the central
nervous system (CNS).
 
RESULTS
 
To assay the ability of cells derived from BM, HSCs, or cir-
culation to engraft hematopoietic and neural lineages within
the brain of recipient mice, we analyzed 21 individual ani-
mals that were engrafted with these cells after either irradia-
tion and transplantation, or parabiosis. Initially, observations
were made by standard immunofluorescence microscopy,
and brains from 14 mice were further analyzed in detail using
confocal microscopy. In all cases, donor cells and their prog-
eny were derived from GFP-transgenic mice, which consti-
tutively express GFP from the ubiquitous 
 
 
 
-actin promoter,
and were transferred into nontransgenic (GFP
 
 
 
) histocom-
patible recipients. Each of the animals selected for study
showed substantial engraftment of the peripheral blood (PB)
by GFP
 
 
 
 donor cells, with chimerism ranging from 5 to 98%
of total PB leukocytes and including contributions to both
the myeloid and lymphoid lineages (see Tables I–III). Some
animals were subjected to brain injury by intraperitoneal KA
injection before analysis. In animals that survived KA injury
(
 
 
 
70% of treated mice), responses in the first 2 h after injec-
tion ranged between grade 2 (focal with myoclonic jerks/
twitches) and grade 5 (secondarily generalized to bilateral
tonic and clonic movements; see Materials and methods).
 
Generation of microglia from transplanted BM or HSCs or 
from circulating cells
 
Initial observations of GFP
 
 
 
 cells identified in the brains of
nontransgenic animals transplanted with GFP-expressing
BM or HSCs revealed that the vast majority of these cells
exhibited morphology typical of microglia. To confirm this
hypothesis, we performed costaining of GFP with the mi-
croglial markers Iba-1 and Mac-1 (Table I and Figs. 1 and 2).
Figure 1. Confocal micrographs depicting microgliosis in the in-
jured hippocampus of irradiated recipient mice, killed 8 d after KA 
injection, and 4.5 mo after transplantation with a single GFP  HSC. 
Tissue sections were costained with Hoechst 33342, anti–Iba-1 and anti-
GFP antibodies. Images represent 10  (A–C) or 40  oil (D–F) magnifica-
tion. Fluorescence shown is as follows: A and D: Hoechst 33342 (blue) and 
Iba-1 (red); B and E: Hoechst 33342 (blue) and GFP (green); C and F: Iba-1 
(red) and GFP. Bar: A–C, 100  m; D–F, 20  m. 
JEM VOL. 201, May 16, 2005
 
1581
 
ARTICLE
 
In all animals evaluated, the percent of donor-derived GFP
 
 
 
cells coexpressing microglial markers ranged from 
 
 
 
51 to
99%. The degree of contribution of transplanted cells to the
generation of microglia appeared similar between animals
transplanted with unfractionated BM cells or with purified
KTLS HSCs, and between animals transplanted at birth or as
adults (Table I). Treatment of animals with KA to induce
hippocampal injury did not appear to increase the frequency
of Iba-1–expressing GFP
 
 
 
 cells (Table I), but did in some
cases induce substantial microgliosis in the area surrounding
the hippocampus; these microglial foci contained cells of
both donor (GFP
 
 
 
) and host (GFP
 
 
 
) origin (Fig. 1). In gen-
eral, although most GFP
 
 
 
 cells found in the brains of BM-
or HSC-transplanted mice appeared to be microglia, the
overall contributions of such cells to the brain-resident mi-
croglial populations were quite low; donor-derived micro-
glia comprised only 0.5–11.5% of resident microglia in the
irradiation/transplant models (including recipients of whole
BM [WBM] and of purified HSCs and despite the observa-
tion that in over half of the animals, contributions to PB leu-
kocytes were 
 
 
 
60%).
GFP
 
 
 
 microglia were also observed in animals joined by
parabiosis. Surgically joined parabiotic animals develop a
common, anastomosed vasculature, with cross-circulation
first detectable 
 
 
 
2–3 d after joining and 
 
 
 
50% mixing of
blood elements achieved within 
 
 
 
10 d (29, 30). Further-
more, rapid and enduring cross-engraftment of BM cells,
and particularly of BM HSCs, has been demonstrated in
parabiotic mice joined for as little as 2 wk (30, 31). Analysis
of nontransgenic animals that had been joined by parabiosis
to GFP-transgenic partners revealed that 
 
 
 
17–43% of the
GFP
 
 
 
 cells found in the brains of these mice coexpressed the
microglial marker Iba-1 (Table I). The overall contribution
of GFP
 
 
 
 cells to brain microglia in these animals was quite
low (0.01–1.38% GFP
 
 
 
 microglia), despite 
 
 
 
50% chimer-
ism of cells in the PB of these mice (Table I). The lower fre-
quency of GFP
 
 
 
 microglia observed in parabiotic mice, as
compared with transplanted animals, may suggest that irradi-
ation-mediated destruction of existing brain-resident micro-
glia facilitates engraftment by cells in the periphery, which
ultimately derive from BM and HSCs. Consistent with the
hypothesis that microglia are normally replaced from periph-
eral sources relatively infrequently, contributions of GFP
 
 
 
cells to the microglial pool were observed at greater fre-
quency in animals joined for 3 or 9 mo (0.04–1.38% GFP
 
 
 
microglia), as compared with animals in which cross-circula-
tion had only recently been established (0–0.02% GFP
 
 
 
 mi-
croglia in mice joined for 9–15 d). Hippocampal injury in-
duced by KA treatment did not appear to increase the rate of
detection of GFP
 
 
 
 microglia in parabiotic mice at these early
time points (Table I).
Together, these data indicate that microglia are engrafted
at low levels from BM cells after standard protocols of irradia-
tion and transplantation, and from circulating cells after para-
Figure 2. Laser scanning confocal images of microglia from brain 
tissue of a single HSC transplanted mouse killed at day 8 after KA 
injection (A–H) or a single HSC transplanted mouse transplanted 
and killed without additional brain injury (I–L). Tissues were stained 
with anti–Mac-1 or anti–Iba-1 antibodies (red); anti-GFP antibody (green); 
and Hoechst 33342 (blue). Fluorescence shown is as follows: GFP (B, F, and 
J); Hoechst 3342 (C, G, and K); Mac-1 (D and H); Iba-1 (L); merged (A, E, 
and I). Bar, 10  m. 
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biosis. These cells most likely derive from HSCs and their
progeny, as animals reconstituted by HSCs appear to show
similar microglial chimerism as animals reconstituted by un-
fractionated BM cells. Such hematopoietic lineage microglia
constitute the vast majority of cells expressing donor-markers
found in the brains of transplanted and parabiotic animals.
 
CD45 immunoreactivity of microglial 
marker-negative population
 
As described before, in most mice, the vast majority of do-
nor-marker–expressing (GFP
 
 
 
) cells found in the brain after
transplant or parabiosis coexpressed the microglial markers
Iba-1 and/or Mac-1; however, some cells in these analyses
failed to stain with these markers. To characterize further the
population of GFP
 
 
 
 cells that failed to stain with microglial
markers, and particularly to evaluate the possibility that these
represent blood cells of nonmicroglial lineage, we costained
brain sections from WBM or HSC-transplanted mice with
the panhematopoietic marker CD45 and Iba-1, or with
CD45 and Mac-1, and analyzed the GFP
 
 
 
 cells using confo-
cal microscopy for expression of these hematopoietic and
microglial markers. Consistent with earlier analyses (31),
very few GFP
 
 
 
 cells failed to costain in these assays. The fre-
quency of donor-marker–expressing (GFP
 
 
 
) cells coexpress-
ing either CD45 and/or Iba-1 or Mac-1 ranged from 
 
 
 
96-
100% for WBM-transplanted mice and from 
 
 
 
98.5–100%
 
Table I.
 
Analysis of microglial marker expression by GFP
 
 
 
 cells in brains of transplanted or parabiotic mice
 
Engraftment
model
Animal
no.
Age at 
transplant
or parabiosis
No. of cells
transplanted
Duration of
survival after
transplant/parabiosis
Injury
model
Hematopoietic
chimerism
at death 
(% GFP
 
 
 
PB leukocytes)
Iba1
 
 
 
 donor cells
per section, mean 
 
 
 
 SD
(total cells analyzed: 
GFP
 
 
 
Iba
 
 
 
/GFP
 
 
 
)
GFP
 
 
 
 microglia
per section, mean 
 
 
 
 SD
(total cells analyzed: 
GFP
 
 
 
Iba
 
 
 
/Iba
 
 
 
)
 
%%
 
WBM
transplant
 
1 newborn 10
 
6
 
9 mo no injury 13 78.8 
 
 
 
 
 
2.2
(167/212, 
 
n
 
 
 
  
 
2)
2.2 
 
 
 
 
 
0.8
(167/7,607, 
 
n
 
 
 
  
 
2)
2 newborn 10
 
6
 
9 mo no injury 5 80.6 
 
 
 
 
 
7.0
(241/299, 
 
n
 
 
 
  
 
3)
4.3 
 
 
 
 
 
2.3
(241/5,613, 
 
n
 
 
 
  
 
3)
3 adult 10
 
6
 
3 mo no injury 88 92.3 
 
 
 
 
 
2.7
(886/960, 
 
n
 
 
 
  
 
3)
11.5 
 
 
 
 
 
1.7
(886/7,697, 
 
n
 
 
 
  
 
3)
4 adult 10
 
6
 
3 mo no injury 63 85.0 
 
 
 
 
 
2.3
(597/703, 
 
n
 
 
 
  
 
2)
6.0 
 
 
 
 
 
0.5
(597/9,890, 
 
n
 
 
 
  
 
2)
5 adult 10
 
6
 
6.5 mo KA 92 90.3 
 
 
 
 
 
5.5
(475/526, 
 
n
 
 
 
  
 
2)
4.8 
 
 
 
 
 
1.8
(475/9,856, 
 
n
 
 
 
  
 
2)
6 adult 10
 
6
 
7 mo KA 94 58.0 
 
 
 
 
 
19.2
(409/705, 
 
n
 
 
 
  
 
2)
4.9 
 
 
 
 0.6
(409/8,393, 
 
n
 
 
 
  
 
2)
HSC
transplant
7 adult 1 3 mo no injury 10 93.1   5.5
(54/58, n   4)
0.5   0.1
(54/10,865, n   4)
8 adult 1 3 mo no injury 72 53.7   23.8
(36/67, n   3)
0.8   0.03
(36/4,363, n   3)
9 adult 1 4.5 mo KA 27 97.6   4.7
(82/84, n   2)
1.5   0.7
(82/6,939, n   2)
10a adult 1 9 mo KA 98 91.0   3.3
(343/377, n   2)
7.2   2.1
(343/4,755, n   2)
11 adult 100 4 mo KA 88 99.3   0.8
(279/281, n   2)
4.7   1.1
(279/5,598, n   2)
12 adult 100 7 mo KA 47 58.1   14.4
(864/1,488, n   2)
10.7   0.4
(864/8,230, n   2)
Parabiosis 13 adult NA 7 mo no injury 22 42.8   23.5
(62/145, n   3)
1.4   0.2
(62/3,302, n   3)
16 adult NA 9 d no injury 60.2 0 0
14 adult NA 9 d KA 52 33.3   70.7
(1/3, n   2)
0.01   0.1
(1/7,380, n   3)
15 adult NA 16 d KA 61 16.7   11.6
(2/12, n   3)
0.02   0.03
(2/11,330, n   4)
17 adult NA 3 mo KA 41 20   44.9
(3/15, n   4)
0.04   0.03
(3/7,733, n   4)
aThis animal received 2   106 unfractionated BM cells from a single HSC transplanted mouse.
NA, not applicable.JEM VOL. 201, May 16, 2005 1583
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for recipients of a single HSC (Table II). Representative
confocal micrographs depicting rare GFP  cells that failed to
costain with hematopoietic and/or microglial markers are
shown in Fig. 3. KA treatment did not appear to increase the
frequency of detection of rare CD45 /Iba-1  or CD45 /
Mac-1  GFP  cells (Table II).
No expression of neuronal and astrocyte markers by GFP  
cells in transplanted or parabiotic mice
To characterize further the donor-marker–expressing (GFP )
cells that failed to express either microglial markers or CD45,
we costained sagittal brain sections with CD45 and Mac1, to-
gether with either NeuN (labeling neurons), Calbindin (label-
ing Purkinje cells), or GFAP (labeling astrocytes). As criteria for
defining neural lineage cells, we required (a) absence of staining
with the hematopoietic marker CD45 and (b) staining with
NeuN or calbindin (neuronal) or with GFAP (astrocytic) or
exhibition of distinctive morphology (Purkinje neurons only).
A summary of the results of these analyses is given in Table III,
with representative confocal micrographs shown in Figs. 4, 5,
and 6. Consistent with previous papers (26–28, 31), a low fre-
quency of GFP  Purkinje neurons was detected among cere-
bellar cells of a subset of transplanted mice (Table III and Fig.
6). However, among five WBM-transplanted, five HSC-trans-
planted, and two parabiotic animals analyzed, we observed no
cells fulfilling the aforementioned criteria as donor-marker–
expressing astrocytes and no cells qualifying as non-Purkinje
neurons. Similar results were obtained using MAP2 instead of
NeuN as a neuronal marker (unpublished data). Within the ol-
factory bulb of one animal transplanted as a newborn with
GFP-expressing BM cells, we observed a GFP  arborizing
process, which was negative for CD45 and showed possible
partial colocalization of GFAP (Fig. 5). In several cases, we ob-
served some candidate neuronal cells that, under lower magni-
fication (40  oil), appeared to coexpress GFP and NeuN;
however, when examined at higher power (100  oil), these
cells exhibited atypical, cell surface localization of NeuN reac-
tivity and coexpressed CD45 (Fig. 4). Therefore, these cells
were excluded as bona fide neurons. Cell surface NeuN signals
may arise due to nonspecific interactions between CD45 
blood cell surface proteins and anti-NeuN antibody, as has
been suggested in other studies (32). The appearance of
NeuN  or GFAP  CD45  cells was not induced by KA injury
or by enhancement of neurogenesis through the provision of a
running wheel, nor did such treatments enhance the detection
of GFP  Purkinje cells (Table III). Thus, other than one GFP 
arborizing process, which was negative for CD45 and showed
partial colocalization of GFAP (Fig. 5), no cells were found to
simultaneously stain positively for NeuN or GFAP and nega-
tively for both CD45 and Mac1 markers in any other animals,
including the KA injured and parabiotic mice (Table III).
Figure 3. Representative laser scanning confocal micrographs of 
mouse brain cells negative for CD45 and microglial markers (Mac-1 
or Iba-1). Animals were transplanted with single HSC (A–C) or whole BM 
(D–O). Tissues were stained with anti-CD45 and anti–Iba-1 (A–C and G–I, 
red) or anti-CD45 and anti–Mac-1 (D–F and J-O, red); anti-GFP (green); 
and Hoechst 33342 (blue). For A–C, CD45 and Iba-1 were detected using 
Alexa633 and Alexa594 dyes, respectively (C, merged image). Bar, 10  m.HEMATOPOIETIC CELL FATE MAINTAINED IN BRAIN | Massengale et al. 1584
These data suggest strongly that BM-derived, HSC-derived,
and circulating precursors do not normally contribute at de-
tectable levels to neuronal or glial lineages in the adult brain.
DISCUSSION
Derivation of microglia from HSCs
Historically, it has been debated whether HSCs or other
components of BM primarily give rise to the microglial pop-
ulation in the brain (33–39). Our data clearly demonstrate
that microglia can be generated in adult animals from direct
transplant of a single HSC. In fact, we found that the major-
ity of cells derived from BM or from HSCs that enter the
brain after transplant differentiate to become microglia, with
between  54 and 98% of donor-derived cells in recipient
brains showing positive immunofluorescent staining for Iba-1,
a known microglial marker (19). Microglial engraftment
was observed in both the presence and absence of treatment
with KA, known for inducing neuroexcitotoxic injury to
the hippocampus (40, 41). The level of microglial chimerism
did not appear to directly correlate with the PB engraftment
rates in these transplanted mice, which ranged from 5 to
98%. Thus, in both a physiological state and in response to
KA injury, transplanted GFP  cells contributed to the mi-
croglia population in the brain, with engraftment rates of
GFP  donor-derived microglia into irradiated recipient
mouse brains ranging from  0.5 to 11.5% of the total resi-
dent microglia population. This is the first study known to
us that proves that a single HSC, without any further manip-
ulation or amplification in vitro, can give rise in vivo to
blood lineages as well as to brain microglia when directly
transplanted into a recipient adult mouse, and can form mi-
croglial nodules at the sites of CNS lesions in KA-injured
Table II. Frequency of GFP  cells in the brains of WBM or HSC transplanted mice failing to express hematopoietic or microglial lineage markers
Engraftment
model
Animal
no.
Age at
transplant
or parabiosis
No. of cells
transplanted
Duration of
survival after
transplant/parabiosis
Injury
model
Hematopoietic chimerism
at death
(% GFP  PB leukocytes)
GFP  nonhematopoietic cells
(CD45 Mac  or CD45 Iba  cells/
total GFP  cells [%])
WBM
transplant
1 newborn 106 9 mo no injury 13 11/281 (3.9%)
2 newborn 106 9 mo no injury 5 4/167 (2.4%)
3 adult 106 3 mo no injury 88 2/128 (1.6%)
4 adult 106 3 mo no injury 63 1/282 (0.4%)
5 adult 106 6.5 mo KA 93 0/102 (0%)
HSC
transplant
8 adult 1 3 mo no injury 72 2/128 (1.56%)
18 adult 1 5 mo no injury 62 0/84 (0%)
9 adult 1 4.5 mo KA 27 0/90 (0%)
Figure 4. Laser scanning confocal micrographs of sections of brain 
tissue from mice transplanted with whole BM as newborns (A–J and 
S–V) or as adults (K–R). Tissue sections were stained with Hoechst 
33342 (blue), anti-NeuN antibody (red), and anti-CD45 antibody (purple) 
and visualized at 63  oil (all images except D, E, I, and J) and 100  oil (D, 
E, I, and J). Apparent NeuN staining visualized under 63  oil objective (C 
and H) was found to weaken (D) or persist as faint positive NeuN staining 
(I) when viewed under the 100  objective (see Discussion). Images shown 
in A–E and S–V are taken from periventricular regions; in F–J, images are 
taken from the hippocampus; in K–N, images are taken from a location 
that included leptomeninges; and in O–R, images are taken from the 
olfactory bulb. Bar, 10  m.JEM VOL. 201, May 16, 2005 1585
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brains. Our data are consistent with HSCs representing the
functional component in the BM responsible for giving rise
to microglia. Significantly, microglial engraftment was also
observed in parabiotic mice, and did not depend on brain in-
jury, demonstrating that circulating PB cells can enter the
brain and contribute to the resident microglial population
without irradiation of the host. Thus, microglia appear nor-
mally to be recruited at a very low rate from circulation. The
ability of such a population of blood cells to communicate
between the adult hematopoietic system and brain paren-
chyma may have potential therapeutic implications as a vehi-
cle for gene therapy or other treatment modalities, particu-
larly in the treatment of CNS diseases resulting from
aberrant microglia metabolism; however, the relatively low
rate of engraftment observed in both transplanted and para-
biotic animals currently remains a significant potential limita-
tion to the immediate utility of such approaches.
Rarity of nonmicroglial, nonhematopoietic fates of 
donor-derived HSCs
Our data indicate that the majority of donor-marker–
expressing cells, other than microglia, that are present after
transplantation of BM and HSCs maintain their hematopoie-
tic identities, as illustrated by positive immunoreactivity with
the panhematopoietic marker, CD45. Many microglia also
maintained CD45 expression. In our study, the rare popula-
tion of cells negative for both CD45 and microglial markers
(Mac-1 or Iba-1) were all found to exhibit both cellular and
nuclear morphology typical of microglia (Fig. 3 and not de-
picted). It is possible that antibodies are not sensitive enough
to react with 100% of the microglia or hematopoietic cells in
the section. Alternatively, hematopoietic-specific protein ex-
pression may be reduced on hematopoietic cells that cross
the blood–brain barrier into brain parenchyma, where the
local cellular environment is different from vascular system.
This possibility has been suggested in other studies, which
characterize microglia as CD45low (42).
In all the animals we studied, including the parabiotic
model, we were unable to confirm the existence of a BM-
derived population of neurons in the olfactory bulb, as ob-
served by others (1, 2, 7, 16). One frequent pattern we ob-
Figure 5. Laser scanning confocal micrographs showing donor 
marker expression in an arborizing structure consistent with an 
apparent cell process in the olfactory bulb of a whole BM–trans-
planted mouse (transplanted at birth). Tissues were stained for anti-
GFP antibody (A–C, green); Hoechst 33342 (B and D, blue), and either anti-
NeuN (C) or anti-GFAP antibodies (F). The green signal in D–F represents 
native fluorescence of GFP without amplification. Images in A–C and D–F 
are separated by 32  m of tissue. Bar, 10  m.
Figure 6. Laser scanning confocal micrographs showing a GFP  
Purkinje cell. Tissues were stained with anti-Calbindin antibody (A, red) 
and Hoechst 33342 (A, blue). GFP signal (A and B, green) is endogenous 
and unamplified.HEMATOPOIETIC CELL FATE MAINTAINED IN BRAIN | Massengale et al. 1586
served was the apparent positive colocalization of NeuN
with GFP under low magnification. However, under higher
magnification, NeuN reactivity was reduced to a thin rim on
the cell surface. Such cells also uniformly coexpressed CD45
or Mac1. Other GFP  cells that showed positive, but very
weak NeuN staining, even under the highest possible mag-
nification, were also invariably CD45 or Mac1 positive. The
aforementioned GFP  cells further exhibited morphology
typical of blood cells (i.e., round cells with surface spicules or
with elongated nuclei typical of microglia). Although some
studies in the literature showed some GFP  cells with stron-
ger apparent NeuN staining, the experimental conditions in
those studies typically involved prolonged secondary anti-
body exposure or used secondary amplification protocols to
increase the intensity of the observed signal. When amplify-
ing what might be subthreshold signal, we feel it is necessary
to also examine the nuclear morphology or apply other re-
strictive and defining markers such as CD45 to accurately
identify a particular cell type.
By morphological analysis, we found one extensive ar-
borizing structure, suggestive of a neuronal or glial subtype
(Fig. 5), in the olfactory bulb of an animal transplanted with
whole BM at birth. A remnant of this arborizing structure
showing a smaller size was observed on another section 32
 m away from the initial section. The fragments of this puta-
tive cell captured in these two sections were both negative for
CD45 (unpublished data). Despite using confocal microscopy
with highest resolution and thinnest optical sections, we
could not determine whether the latter section showing the
smaller processes reflects true but low immunoreactivity of
GFAP or an artifact, or possibly results from close proximity
of surrounding GFAP  cells. No other cells were found to
coexpress GFP and GFAP in the animals analyzed (Table III).
As the cell body was not located, we could not perform fur-
ther analysis to study its nucleus, and cannot offer evidence as
to the true identity of this cell, or whether it arose as a result
of cell fusion or differentiation of a GFP  cell.
Based on our data, we conclude that HSCs and their
progeny largely maintain restricted cell fates after entering
the brain. The vast majority of blood cells that enter brain in
adults become microglia or exhibit other hematopoietic cell
fates, as evidenced by CD45 or Mac1 expression. Out of 21
animals and  10,000 GFP positive cells we analyzed, both
by morphology and by marker studies, we found only one
possible neuronal or glial phenotype outside the cerebellum,
in an animal that was transplanted with whole BM as a
newborn. Occurrence at a frequency of 1/21 animals and
1/10,000 donor-marker–expressing cells is an extremely rare
Table III. Frequency of GFP  cells in the brains of transplanted or parabiotic mice expressing neural lineage markers
No. GFP  neurons
Engraftment
model
Animal
no.
Age at
transplant or
parabiosis
No. of cells
transplanted
Duration of
survival after
transplant/
parabiosis
Injury
model
Blood chimerism
at death
(% GFP  PB cells)
No. GFP 
Purkinje cells
(calbindin  GFP 
mormorphologically
identified cells/
total GFP  cells)
Markers
evaluated
No. of
qualifying
cells/
total GFP 
cells
No. GFP 
astrocytesa
(GFP GFAP /
total GFP  cells)
WBM
transplant
1 newborn 106 9 mo no injury 13 1/1,099 NeuN , CD45  0/412 0/209
2 newborn 106 9 mo no injury 5 5/1,287 NeuN , CD45  0/451 0/182
3 adult 106 3 mo no injury 88 0/600 NeuN , CD45 ,
Mac 
0/291 0/310
4 adult 106 3 mo no injury 63 0/680 NeuN , CD45 ,
Mac 
0/385 0/295
5 adult 106 6.5 mo KA 92 0/429 NeuN , CD45 ,
Mac1 
0/198 0/231
6 adult 106 7 mo KA 94 0/1,065 NeuN , CD45- 0/1,010 0/55
HSC
transplant
8 adult 1 3 mo no injury 72 0/538 NeuN , CD45-,
Mac1 
0/105 0/65
19 adult 100 5 mo running 98 0/259 NeuN , CD45  0/259 ND
20 adult 100 5 mo running 98 0/161 NeuN , CD45  0/161 ND
9 adult 1 4.5 mo KA 27 0/183 NeuN , CD45  0/42 0/51
10b adult 1 9 mo KA 98 0/710 NeuN , CD45  0/655 0/55
Parabiosis 21c adult NA 7 mo no injury 46 0/16 NeuN , CD45  0/14 0/2
17 adult NA 3 mo KA 41 0/79 NeuN , CD45  0/62 0/17
aThe number of GFP  cells per section evaluated in the GFAP study was estimated from the average number of GFP  cells in several representative sections from the same animal.
bThis animal received 2   106 unfractionated BM cells from an animal previously transplanted with a single HSC.
cAnimal 21 was injected intramuscularly with cardiotoxin 8 wk before being killed, which has no known effects on the brain.
NA, not applicable.JEM VOL. 201, May 16, 2005 1587
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event, and calls into question the importance of such phe-
nomena to normal homeostasis and physiological or thera-
peutic cell replacement in the adult CNS.
MATERIALS AND METHODS
Animals.  C57BL/Ka, C57BL/Ka-Thy-1.1, and C57BL/Ka-Ly5.2/Thy-
1.1 mouse strains were bred and maintained at the Stanford University Re-
search Animal Facility. eGFP-transgenic mice were generated by us as de-
scribed previously (43), and were backcrossed for at least 10 generations to
C57BL/Ka-Thy-1.1 mice. GFP-transgenic mice used as BM donors in
these studies were 6–12 wk old. Nontransgenic C57BL/Ka mice were
transplanted either at birth (postnatal days 0 or 1) or as adults, at 8–16 wk of
age. For parabiosis, animals were joined at 6–10 wk of age. Mice were
killed at 3–12 mo after transplant and 8–15 d after KA injury, where appli-
cable, by intracardiac perfusion, performed under anesthesia (avertin 15  l/g
body weight), with 20 ml of 10mM EDTA followed by 20 ml of 2–4%
paraformaldehyde. Animal care and experimental protocols were performed
in accordance with procedures and guidelines established by the Stanford
University Administrative Panel for Lab Animal Care for the humane care
and use of animals.
BM harvesting. BM cells were flushed from femurs and tibiae of donor
mice with a 1-ml syringe and 21-gauge needle containing HBSS (Invitro-
gen) supplemented with 2% FCS. Red blood cells subsequently were lysed
by a 3-min incubation in 0.15 M ammonium chloride and 0.01 M potas-
sium bicarbonate solution on ice. Leukocytes were counted on a hemocy-
tometer and used for transplantation or for HSC staining and sorting (see
next paragraph).
FACS of HSCs. GFP  HSCs were isolated by double FACS sorting of
c-kit–enriched BM from GFP-transgenic mice, based on previously defined
reactivity for particular cell surface markers (KTLS; references 44–46) as de-
scribed previously (47). All antibody incubations were performed on ice for
15–25 min. BM cells were first stained with purified lineage antibodies, in-
cluding KT31.1 (anti-CD3), GK1.5 (anti-CD4), 53–7.3 (anti-CD5), 53–
6.7 (anti-CD8), Ter119 (antierythrocyte-specific antigen), 6B2 (anti-B220),
8C5 (anti–Gr-1), and M1/70 (anti–Mac-1), followed by anti–rat Cy5PE
(Caltag). Lineage-stained cells were further stained for c-kit with biotinyl-
ated 3C11 and c-kit–positive cells were enriched by positive selection using
MACS (Miltenyi Biotec) streptavidin-conjugated magnetic beads and Au-
toMACS cell separator columns according to manufacturer’s instructions.
c-kit–enriched cells were stained with fluorescently labeled 2B8 (anti–c-kit),
19XE5 (anti-Thy1.1), and E13-161.7 (anti–Sca-1) monoclonal antibodies
to identify HSCs. 3C11 and 2B8 recognize distinct, nonoverlapping
epitopes of c-kit. Before FACS analysis, cells were suspended in 1  g/ml of
propidium iodide to identify and exclude dead (propidium iodide ) cells.
KTLS HSC populations were double sorted to ensure purity, using a highly
modified Vantage SE (BD Biosciences), provided by the Stanford Univer-
sity Shared FACS Facility. Flow cytometry data was analyzed using FlowJo
(Treestar) analysis software.
Hematopoietic cell transplantation.  Adult C57BL/Ka recipient mice
received a lethal dose of irradiation (950 rad, delivered in a split dose 3 h
apart) before transplantation by retroorbital injection with GFP  cells iso-
lated from donor mice carrying the eGFP transgene, driven by the  -actin
promoter (43, 48). Newborn animals were preconditioned with a sublethal
dose of irradiation (400 rad, delivered in a split dose 3 h apart) before trans-
plant via intrahepatic injection. Both adult and newborn recipient mice
were transplanted with 106–5   107 GFP  BM cells, or with 1 or 100
FACS-purified GFP  KTLS HSCs. B cells, T cells, and myeloid cells in the
PB of reconstituted animals were identified by flow cytometry using anti-
B220, anti-CD3, or anti–Mac-1/anti–Gr-1, respectively. All transplanted
mice analyzed in these studies showed significant levels of multilineage chi-
merism of PB leukocytes, as indicated in Tables I–III.
Parabiosis. Parabiosis surgery was performed exactly as described previ-
ously (30), and in accordance with the guidelines established by the Stan-
ford University Administrative Panel for Lab Animal Care for the humane
care and use of animals.
KA injury.  To induce injury to hippocampal neurons, some animals
were treated with KA. For transplanted animals, KA was administered 2–4
mo after transplant, whereas for parabiotic animals, KA was given 24 h be-
fore parabiosis. Animals were first anesthetized using 3% isofluorane before
intraperitoneal injection of 20 mg/kg KA (Sigma-Aldrich) prepared at 10
mg/ml in sterile PBS. Animals were warmed and observed for up to 8 h af-
ter KA injection. In all KA-treated animals, seizures began  5–10 min after
injection, and recurred for a period of up to 3 h. Responses of individual
animals to KA injection were scored every 5 min for the first 2 h and every
15 min for the next 2 h as follows: 0, no effect; 1, arrest of motion; 2, myo-
clonic jerks of the head and neck, with brief twitching movements; 3, uni-
lateral clonic activity; 4, bilateral forelimb tonic and clonic activity; and 5,
generalized tonic-clonic activity with loss of postural tone including death
from continuous convulsions, as described previously (40, 41). Mortality
among all KA-treated animals was  30%. Animals that survived KA treat-
ment showed a similar range of seizure grades, generally between grades 2
and 5 in the first 2 h after injection.
Running wheel exercise.  In some experiments, mice were provided
with running wheels for a period of 28 d before being killed. Mice were
observed to engage in this exercise readily and voluntarily.
Immunofluorescence. After perfusion, brains were harvested from con-
trol, transplanted, or parabiotic animals and subsequently fixed in 2–4%
paraformaldehyde overnight, followed by cryopreservation in 30% sucrose
at 4 C until submerged (usually overnight). Cryostat sagittal sections, in-
cluding the olfactory bulb, cortex, and cerebellum, were cut at a 5–16- m
thickness and placed onto Superfrost/Plus slides, dehydrated, and stored at
 80 C until use. Citrate buffer and heat antigen retrieval was performed on
sections for NeuN staining per standard protocol. Sections were permeabi-
lized and blocked in 3% goat serum with 0.3% Triton X-100 and stained
with primary antibodies at room temperature for 1–3 h or at a 4 C for 16–
48 h in light-protected humid chambers. Mouse-on-mouse (MOM) immu-
nodetection kit (Vector Laboratories) was used for staining with antibodies
raised in mouse. Primary antibodies used included mouse anti-NeuN
(Chemicon International), mouse anti-MAP2 (Chemicon), 1:400; rabbit
anticalbindin (Chemicon), 1:400; rabbit anti–cow GFAP (DakoCytoma-
tion), polyclonal, 1:2,000; rat anti-Mac1 (eBioscience), 1:50; rabbit anti-
Iba1 (a gift from Y. Imai, National Institute of Neuroscience, Tokyo, Ja-
pan), polyclonal, 1:600; rat anti-CD45 (BD Biosciences), 1:100; and rabbit
anti-GFP conjugated with Alexa Fluor-488 (Molecular Probes), 1:250. Sec-
ondary antibodies used included goat anti–mouse conjugated with Alexa
Fluor-594, goat anti–rabbit conjugated with Alexa Fluor-594, and goat
anti–rat conjugated with Alexa-594 or Alexa Fluor-633 (Molecular Probes).
Nuclei were stained with Hoechst 1:1,000 (Molecular Probes). Stained sec-
tions were analyzed for coexpression of the indicated markers by confocal
microscopy. This analysis typically included all fields of the sagittal brain
sections, representing olfactory bulb, cortex, cerebellum, choroid plexus,
and periventricular (including subventricular) regions of the brain.
Confocal microscopy. Images were collected using a 63  (N.A 1.4) or
100  (N.A. 1.4) oil immersion on a Leica SP2 AOBS or a Zeiss LSM510
laser scanning confocal microscope as indicated. On the Leica system,
zooming was performed during the optical data collection using a pin hole
size of 1 Airy unit, and the optimal Z axis step size (as indicated by the soft-
ware) was used to collect data for Z stack series. Images were processed with
Adobe Photoshop for presentation.
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